Early health economic assessment of eLi 12 , a new method to estimate 12-hour lithium levels when blood sampling deviates from 12 hours

Key Points

• The aim is to assess the health economic potential of eLi12 for estimating 12-hour lithium levels when blood sampling deviates.
• Conducted an early health economic assessment of eLi12.
• Evaluated its potential for healthcare savings.
• Guided investment decisions related to clinical implementation.
• Identified significant healthcare savings from using eLi12.
• Highlighted the importance of studying its clinical implementation.